ArticleDigestive diseases and sciences2026
Hepatitis B Screening, Antiviral Prophylaxis, and Reactivation Risk in Rituximab-Treated Patients: A 17-Year Population-Based Cohort Study Highlighting Current Practices and Gaps.
Fadi Abu Baker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.